Liver Fibrosis Quantification and Analysis: The LiQA Dataset and Baseline Method
By: Yuanye Liu , Hanxiao Zhang , Nannan Shi and more
Potential Business Impact:
Helps doctors find liver disease from scans.
Liver fibrosis represents a significant global health burden, necessitating accurate staging for effective clinical management. This report introduces the LiQA (Liver Fibrosis Quantification and Analysis) dataset, established as part of the CARE 2024 challenge. Comprising $440$ patients with multi-phase, multi-center MRI scans, the dataset is curated to benchmark algorithms for Liver Segmentation (LiSeg) and Liver Fibrosis Staging (LiFS) under complex real-world conditions, including domain shifts, missing modalities, and spatial misalignment. We further describe the challenge's top-performing methodology, which integrates a semi-supervised learning framework with external data for robust segmentation, and utilizes a multi-view consensus approach with Class Activation Map (CAM)-based regularization for staging. Evaluation of this baseline demonstrates that leveraging multi-source data and anatomical constraints significantly enhances model robustness in clinical settings.
Similar Papers
DLiPath: A Benchmark for the Comprehensive Assessment of Donor Liver Based on Histopathological Image Dataset
Image and Video Processing
Helps doctors quickly check donated livers for transplant.
Label-Efficient Cross-Modality Generalization for Liver Segmentation in Multi-Phase MRI
CV and Pattern Recognition
Helps doctors see liver problems better on scans.
Hybrid Approach Combining Ultrasound and Blood Test Analysis with a Voting Classifier for Accurate Liver Fibrosis and Cirrhosis Assessment
CV and Pattern Recognition
Finds liver disease early using scans and tests.